EZH2抑制劑和調節性T細胞功能的調製

• 收藏
• 分享

专利权人:

Constellation Pharmaceuticals; Inc.

发明人:

Srimoyee GHOSH,Jose, M. LORA

申请号：

HK18115733

公开号：

HK1256604A1

申请日:

2018.12.07

申请国别(地区):

HK

年份:

2019

代理人:

摘要：

Provided herein are methods of treating cancers characterized by a high frequency of one or more suppressive immune cells, comprising administering a therapeutically effective amount of an enhancer of zeste homolog 2 (EZH2) inhibitor. Also provided are combination therapies using an EZH2 inhibitor and a second agent that is an immunomodulator.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/